Home / Inspections / 1237401

FDA Inspection 1237401 — Carter BloodCare - Baylor

Carter BloodCare - Baylor — FEI 1674451

The FDA completed an inspection of Carter BloodCare - Baylor on April 26, 2024 in Dallas, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 26, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Dallas, TX (United States)

Facility

Other inspections at this facility

  • 1098356 (VAI Thu Jul 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 927574 (NAI Wed May 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 818049 (NAI Thu Feb 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 733844 (NAI Fri Jul 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 631572 (NAI Wed Dec 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources